Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome

Anifrolumab 300 mg will be administered in intravenous infusions once per 4 weeks, for a total treatment period of 24 weeks.

Placebo will be administered in intravenous infusions once per 4 weeks, for a total treatment period of 24 weeks.